Abstract:Apoptosis is a mode of programmed cell death that plays important roles in tissue sculpting during development, in the maintenance of tissue homeostasis in the adult, and in the eradication of injured or infected cells during pathological processes. Numerous physiological as well as pathological stimuli trigger apoptosis, such as engagement of plasma‐membrane‐associated Fas, TRAIL, or TNF receptors, growth factor deprivation, hypoxia, radiation, and exposure to diverse cytotoxic drugs. Apoptosis is coordinated by members of the caspase family of cysteine proteases, which, upon activation, trigger a series of dramatic morphological and biochemical changes including retraction from the substratum, cell shrinkage, extensive and protracted plasma membrane blebbing, chromatin condensation, DNA hydrolysis, nuclear fragmentation, and proteolytic cleavage of numerous caspase substrates. These dramatic structural and biochemical alterations result not only in the controlled dismantling of the cell, but also in the rapid recognition and removal of apoptotic cells by phagocytes through the cell surface display of phagocytotic triggers such as phosphatidylserine. Necrosis, which is typically nonprogrammed or imposed upon the cell by overwhelming membrane or organelle damage, is characterized by high‐amplitude cell swelling, followed by rapid plasma membrane rupture and release of cellular contents into the extracellular space. Necrosis is often provoked by infectious agents or severe departure from physiological conditions due to toxins, temperature extremes, or physical injury. However, forms of programmed necrosis (necroptosis, pyroptosis, ferroptosis) can also occur in specific circumstances. Nonprogrammed and programmed necrosis can be distinguished from apoptosis by morphological features, based on the rapid uptake of vital dyes, and through the application of specific inhibitors of key molecules associated with the latter modes of cell death. This unit describes protocols for the measurement of apoptosis and necrosis and for distinguishing apoptosis from programmed as well as conventional necrosis. © 2023 The Authors. Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Analysis of cell morphology by phase‐contrast microscopy Alternative Protocol 1: Assessment of morphological changes using eosin‐methylene blue staining Alternative Protocol 2: Analysis of nuclear morphology by fluorescence microscopy Support Protocol: Preparation of cytospins Basic Protocol 2: Measurement of plasma membrane composition with annexin V and propidium iodide Basic Protocol 3: Measurement of DNA fragmentation by flow cytometry Alternative Protocol 3: Analysis of DNA fragmentation by the TUNEL assay Basic Protocol 4: Measurement of caspase activation by flow cytometry Basic Protocol 5: Discriminating between apoptosis, necrosis, necroptosis, and ferroptosis

High‐throughput mechano‐cytometry as a method to detect apoptosis, necroptosis, and ferroptosis

Automated measurement of cell mechanical properties using an integrated dielectrophoretic microfluidic device

Discriminating Between Apoptosis, Necrosis, Necroptosis, and Ferroptosis by Microscopy and Flow Cytometry

In Vivo Identification of Apoptotic and Extracellular Vesicle-Bound Live Cells Using Image-Based Deep Learning

A Real‐Time Image‐Based Approach to Distinguish and Discriminate Apoptosis from Necrosis

High-throughput single-cell mechanical phenotyping with real-time deformability cytometry

A Microfluidic Device Based On Gravity And Electric Force Driving For Flow Cytometry And Fluorescence Activated Cell Sorting

Real-time viscoelastic deformability cytometry: High-throughput mechanical phenotyping of liquid and solid biopsies

Label-free electrical discrimination of cells at normal, apoptotic and necrotic status with a microfluidic device.

Hydrodynamic stretching of single cells for large population mechanical phenotyping

High throughput cell mechanotyping of cell response to cytoskeletal modulations using a microfluidic cell deformation system

Microfluidic technologies for cell deformability cytometry

Electronic detection of apoptotic cells on a microchip

Non-invasive Detection and Differentiation of Apoptotic and Necroptotic Cell Death in Vitro.

In vitro assay for single-cell characterization of impaired deformability in red blood cells under recurrent episodes of hypoxia

A 3D Cell Death Assay to Quantitatively Determine Ferroptosis in Spheroids

A sheath-less electric impedance micro-flow cytometry device for rapid label-free cell classification and viability testing

Real-time Detection of Circulating Apoptotic Cells by in Vivo Flow Cytometry

High-throughput Adjustable Deformability Cytometry Utilizing Elasto-Inertial Focusing and Virtual Fluidic Channel.

Plasmon-enhanced Raman Spectroscopic Metrics for in Situ Quantitative and Dynamic Assays of Cell Apoptosis and Necrosis.